Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells
Chiara F. Magnani(University of Zurich), Markus G. Manz(Ospedale San Giovanni Bellinzona)
Cited by 31
Related Papers
Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities
|Journal of Clinical Investigation|2020|185
The Past, Present, and Future of Non-Viral CAR T Cells
|Frontiers in Immunology|2022|141
Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells
|Leukemia|2020|90
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma
|Nature Cancer|2023|42
Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden
|Hematological Oncology|2019|34